skip to main content
Show Results with:

Genomic Profiling of HER2‐Positive Gastric Cancer: PI3K/Akt/mTOR Pathway as Predictor of Outcomes in HER2‐Positive Advanced Gastric Cancer Treated with Trastuzumab

Díaz‐Serrano, Asunción et al.

The oncologist. Volume 23:Number 9 (2018, September); pp 1092-1102 -- AlphaMed Press

Online access

Searching Remote Databases, Please Wait